Understanding the Importance of Neuropathy Testing in Diabetic Neuropathy Patients

Diabetic Neuropathy Screening Test: How It Works, What It Detects & Why Early Testing Matters

Diabetic neuropathy is one of the most common and serious complications of diabetes, affecting nearly 50% of all diabetic patients at some point. It results from prolonged high blood sugar levels that gradually damage nerves throughout the body — most severely in the feet and legs. Left undetected, it leads to foot ulcers, infections, and in extreme cases, amputation.

The good news is that diabetic neuropathy can be detected early with the right screening tests—and early detection makes a significant difference in patient outcomes. This article explains the types of diabetic neuropathy, how testing works, what equipment is used, and why routine screening is critical for every diabetic patient.

What Is Diabetic Neuropathy?

Diabetic neuropathy is nerve damage caused by chronically elevated blood glucose levels. When blood sugar remains high over a long period, it damages the walls of the small blood vessels that supply nerves with oxygen and nutrients. This disruption causes nerves to malfunction and, over time, to deteriorate.

The condition most commonly affects the peripheral nerves — those in the feet, legs, hands, and arms — but it can also damage nerves in the digestive system, urinary tract, heart, and blood vessels depending on the type.

Types of Diabetic Neuropathy

• Peripheral Neuropathy: The most common form. It primarily affects the feet and legs before the hands and arms. Patients experience numbness, tingling, burning pain, and reduced sensation—particularly in the soles of the feet.
• Autonomic Neuropathy: This type affects the autonomic nervous system, which controls involuntary functions like heart rate, digestion, bladder control, and blood pressure. Patients may experience digestive issues, irregular heart rate, or inability to sense hypoglycemia.
• Mononeuropathy (Focal Neuropathy): Affects a single, specific nerve—often in the wrist, thigh, or face. It can cause sudden weakness or pain and typically resolves on its own over time.
• Radiculoplexus Neuropathy: Also called diabetic amyotrophy, this affects the nerves in the hips, thighs, buttocks, and legs. It typically causes sudden, severe pain followed by weakness.

What Are the Symptoms of Diabetic Neuropathy?

Recognizing the symptoms of diabetic neuropathy early is the first step toward prevention and management. Common symptoms include:

• Numbness or reduced ability to feel pain or temperature in the feet and legs
• Tingling or burning sensation in the feet—especially at night (burning feet diabetes)
• Sharp, stabbing, or electric shock-like pain in the lower limbs
• Muscle weakness and difficulty walking
• Extreme sensitivity to touch—even light pressure on the feet may feel painful
• Foot ulcers, infections, or wounds that heal slowly
• Digestive issues such as bloating, nausea, or constipation (in autonomic neuropathy)

Not all foot pain in a diabetic patient is due to neuropathy. That is why proper diagnostic testing is essential to accurately identify the condition and guide treatment.

How Is Diabetic Neuropathy Tested?

A thorough neuropathy examination typically includes a combination of clinical assessment and specialised equipment-based tests. The goal is to measure the degree of nerve damage, identify the type of neuropathy, and assess the patient’s risk of developing serious complications such as foot ulcers.

Clinical Neuropathy Examination

A physician will begin with a physical neuropathy examination—assessing the patient’s reflexes, muscle strength, and sensitivity to touch, pinprick, and temperature in the feet and legs. This provides an initial picture but must be confirmed with quantitative testing.

Vibration Perception Threshold (VPT) Test — Biothesiometry

The Vibration Perception Threshold (VPT) test using a biothesiometer is the gold standard for diabetic neuropathy screening. VPT stands for Vibration Perception Threshold, and the test measures how well a patient can perceive vibration at a specific frequency applied to the feet.

How the VPT test works: A vibrating probe is gently placed on the patient’s foot—typically on the tip of the big toe and the ball of the foot. The voltage (vibration amplitude) is gradually increased until the patient signals that they can feel the vibration. This value, measured in volts, is the VPT score.

VPT Score Interpretation:

• VPT < 15V: Normal sensation — low risk
• VPT 15–25V: Impaired sensation — moderate risk of ulceration
• VPT > 25V: Severely reduced sensation — high risk of foot ulcer

A higher VPT value means the patient requires more vibration stimulus to perceive sensation—indicating greater nerve damage and a significantly elevated risk of diabetic foot ulcers and complications.

Kody Medical’s Biothesiometer for Neuropathy Screening

Kody Medical’s Biothesiometer is a digital, portable neuropathy screening device designed specifically for diabetic neuropathy assessment. It features:

• Manual control for applying vibration, helping reach the target level faster and reducing total testing time
• Digital display for accurate and reproducible VPT readings
• Lightweight and portable design — suitable for clinical use, camps, and point-of-care settings
• Easy-to-use software for recording and tracking patient data over time

Monofilament-Test

The Semmes-Weinstein monofilament test is another standard screening tool used in diabetic foot examinations. A thin nylon filament is pressed against specific points on the foot. If the patient cannot feel the filament, it indicates significant loss of protective sensation — a major risk factor for foot ulcers.

Nerve Conduction Studies (NCS)

For more detailed diagnostic testing of diabetic neuropathy, nerve conduction studies measure the speed at which electrical signals travel through the nerves. Slowed conduction velocity confirms peripheral neuropathy. This is typically performed by a neurologist in a clinical setting.

Importance of Neuropathy Testing in Diabetic Patients

Routine neuropathy testing is a cornerstone of comprehensive diabetes management. Here is why it matters:

1. Early Detection Prevents Severe Complications

Many patients are unaware they have diabetic neuropathy until the damage is already advanced. Routine screening — particularly the VPT test — enables healthcare providers to identify nerve damage at an early stage, before the patient develops foot ulcers, infections, or Charcot foot. Early intervention can slow or halt the progression of neuropathy.

2. Accurate Diagnosis Enables Targeted Treatment

Not all limb pain in a diabetic patient is neuropathic. Testing confirms the diagnosis and identifies the type of neuropathy—peripheral, autonomic, mononeuropathic, or radiculoplexus—enabling a targeted treatment plan rather than a generalized approach.

3. Risk Stratification for Diabetic Foot Care

The VPT score directly informs a patient’s foot ulcer risk category. Patients with high VPT scores require more intensive foot care, customized footwear, and more frequent clinical review. This risk stratification approach—enabled by biothesiometry—is central to preventing diabetic foot complications.

4. Monitoring Treatment Effectiveness

Regular neuropathy testing allows healthcare providers to track whether a patient’s nerve function is stable, improving, or deteriorating over time. Serial VPT measurements provide objective data to evaluate the effectiveness of blood sugar control, medication, and lifestyle interventions.

5. Preventing Amputations

Peripheral neuropathy is the leading cause of lower limb amputations in diabetic patients. By identifying at-risk patients early and implementing appropriate wound care, protective footwear, and patient education, routine screening directly contributes to amputation prevention.

Treatment and Management of Diabetic Neuropathy

While diabetic neuropathy cannot be fully reversed, its progression can be slowed—and symptoms can be managed effectively with early and consistent intervention.

Blood Sugar Management

Maintaining stable blood glucose levels is the single most effective strategy for slowing the progression of diabetic neuropathy. Tight glycemic control reduces the rate of nerve damage and can even allow partial recovery in early-stage neuropathy.

Medication

Pain and discomfort from neuropathy are typically managed with medications such as anticonvulsants (e.g., gabapentin, pregabalin), antidepressants (e.g., duloxetine), and topical treatments. Specific medication will be prescribed based on the type and severity of neuropathy identified during testing.

Foot Care and Protective Footwear

Patients with high VPT scores or confirmed peripheral neuropathy require regular foot examinations, proper diabetic footwear, and daily foot care routines to prevent pressure points, blisters, and ulcers from going unnoticed. Kody Medical also supplies diabetic foot care products and podiatry equipment to support comprehensive foot management.

Lifestyle Modifications

A healthy diet, regular physical activity, smoking cessation, and weight management all contribute to better glycemic control and reduced neuropathy progression. These lifestyle changes complement medical treatment and regular screening.

Can Diabetic Neuropathy Be Reversed?

In most cases, established diabetic neuropathy cannot be completely reversed. However, early-stage neuropathy—detected through routine VPT testing—can sometimes show improvement with aggressive blood sugar control and lifestyle changes. The key is early detection. Patients who are screened regularly and identified early have the best chance of preserving nerve function and avoiding the severe complications associated with advanced neuropathy.

Who Should Be Screened for Diabetic Neuropathy?

According to standard clinical guidelines, the following patients should undergo routine neuropathy screening:

• All Type 2 diabetic patients — from the time of diagnosis
• Type 1 diabetic patients — starting 5 years after diagnosis
• Any diabetic patient with foot symptoms (numbness, burning, tingling, or pain)
• Patients with a history of foot ulcers or prior amputations
• Patients with poor glycaemic control or long-standing diabetes

The recommended screening frequency is at least once a year for all diabetic patients, with more frequent testing for those at elevated risk.

Frequently Asked Questions (FAQ)

1) What is a neuropathy screening test?

A neuropathy screening test measures nerve function and detects nerve damage in diabetic patients. The most common method is the Vibration Perception Threshold (VPT) test performed with a biothesiometer, which measures how well the patient can sense vibration in the feet and legs.

2) What is the VPT test full form in medical?

VPT stands for Vibration Perception Threshold. It is a quantitative test used to measure peripheral nerve sensitivity, particularly in diabetic patients at risk of foot ulcers. The test is performed using a biothesiometer—a device that applies controlled vibration to the foot and measures the minimum amplitude the patient can perceive.

3) What is a biothesiometry test?

Biothesiometry is a non-invasive diagnostic test that uses a vibrating probe—the biothesiometer—placed on specific points of the foot. The vibration amplitude is gradually increased until the patient feels it. The result (the VPT score in volts) indicates the degree of nerve damage and the patient’s risk level for diabetic foot complications.

4) How is diabetic neuropathy diagnosed?

Diabetic neuropathy is diagnosed through a combination of clinical neuropathy examination (assessing reflexes, muscle strength, and foot sensitivity) and quantitative tests such as the VPT test (biothesiometer), monofilament test, and nerve conduction studies. The biothesiometer is the preferred tool for routine clinic-based screening.

5) What are the tests for diabetic neuropathy?

The main tests for diabetic neuropathy include:
(1) Biothesiometry / VPT test — measures vibration perception using a biothesiometer
(2) Monofilament test — checks protective sensation in the feet
(3) Nerve conduction studies—measures electrical signal speed through nerves
(4) Clinical neuropathy examination—assesses reflexes, sensation, and muscle strength.

6) Can diabetic neuropathy be cured or reversed?

Diabetic neuropathy cannot be fully cured, but its progression can be slowed with strict blood glucose control, medication, and lifestyle changes. Early-stage neuropathy detected through regular VPT screening can sometimes improve with timely intervention. This is why routine screening from the time of diabetes diagnosis is so important.

7) What happens if diabetic neuropathy is left untreated?

Untreated diabetic neuropathy can lead to progressive nerve damage, loss of protective sensation in the feet, diabetic foot ulcers, deep tissue infections, Charcot foot deformity, and ultimately lower limb amputation. Autonomic neuropathy, if untreated, can affect heart rate regulation and digestive function.

8) How often should diabetic patients be screened for neuropathy?

All diabetic patients should undergo neuropathy screening at least once a year. Patients with existing symptoms, a history of foot ulcers, high VPT scores, or poor glycemic control may require more frequent screening—as recommended by their diabetologist or podiatrist.

9) What diabetic neuropathy equipment does Kody Medical supply?

Kody Medical supplies a range of diabetic neuropathy screening and foot care equipment in India, including the Biothesiometer (VPT test device), monofilament kits, and complete diabetic foot care systems. Kody Medical also provides vascular Doppler systems, ABI/TBI instruments, podiatry equipment, and the KODYS Foot Clinic software for integrated patient management.

About Kody Medical’s Diabetic Neuropathy Equipment

Kody Medical based in Chennai, India, is a leading supplier of diabetic neuropathy screening equipment and diabetic foot care products. Kody Medical’s Biothesiometer is a clinically validated VPT testing device trusted by diabetologists, podiatrists, and vascular specialists across India.

Key features of Kody Medical’s Biothesiometer:

• Manual vibration control for faster, more accurate VPT measurement
• Portable and lightweight — ideal for clinic, hospital, and camp settings
• User-friendly digital interface with data recording capability
• Reduces total testing time compared to conventional biothesiometers

In addition to neuropathy equipment, Kody Medical supplies vascular Doppler systems, automatic ABI/TBI/PVR systems, diabetic retinopathy equipment, surgical Doppler probes, diabetic foot care products, podiatry equipment, and the KODYS Foot Clinik software—providing a complete ecosystem of tools for diabetic foot and vascular care.